Virtual Care for Acute Kidney Injury
(UPTAKE-VC Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment Virtual Care, Telemedicine, Remote Monitoring, Virtual Home Hospital for Acute Kidney Injury?
Research shows that remote patient management, a form of virtual care, improves outcomes for patients on home-based dialysis by allowing early problem detection and reducing hospital visits. Additionally, telemedicine has been effective in managing critically ill patients in rural areas, maintaining healthcare standards without the need for long-distance travel.12345
Is virtual care safe for patients with kidney conditions?
Virtual care, including telemedicine and remote monitoring, has been used safely for patients with chronic kidney disease (CKD) to improve care and monitor health. Studies show that virtual care can help manage CKD effectively, with no emergency dialysis needed and similar survival rates to traditional care. Additionally, patients reported high satisfaction and found virtual care helpful, especially during the COVID-19 pandemic.46789
How is the Virtual Care treatment for acute kidney injury different from other treatments?
What is the purpose of this trial?
Method: Randomized Controlled Trial Study Duration: 3 Years Study Centre(s) University of Calgary and University of Alberta Objectives: To fill care gaps by implementing strategies to reduce length of hospital stay, readmission rates, and improve long-term outcomes after Acute Kidney Injury (AKI). Number of Participants: Three Hundred and fifty four (n=354) Diagnosis and Main Inclusion Criteria: Hospitalized adults with AKI at high risk of hospital readmission or deathStudy Intervention: Multi-component Digital Health Solutions, including:1. Computerized Clinical Decision Support (CDS) and2. Virtual Care Delivered through Hospital at Home (VC) Duration of administration: Determined by the Patient's clinical team Reference therapy: Usual Care Statistical Analyses: Descriptive Analysis, Regression
Research Team
Matthew James, MD
Principal Investigator
University of Calgary
Eligibility Criteria
This trial is for hospitalized adults with Acute Kidney Injury (AKI) who are at high risk of being readmitted to the hospital or dying. The study aims to help these individuals by using virtual care strategies.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Vanguard Phase
Initial implementation to establish feasibility and acceptability of the intervention
Treatment
Participants receive virtual care through Virtual Home Hospital programs, including digital remote patient monitoring and regular virtual assessments
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of kidney function and complications of AKI
Treatment Details
Interventions
- Virtual Care
Virtual Care is already approved in Canada for the following indications:
- Acute Kidney Injury (AKI)
- Reducing hospital readmission rates
- Improving long-term outcomes
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Alberta Health services
Collaborator